INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 186 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,026,800 | +188.8% | 225,376 | +2564.3% | 0.01% | +150.0% |
| Q4 2019 | $1,048,000 | +394.3% | 8,459 | +218.0% | 0.00% | – |
| Q2 2019 | $212,000 | -18.8% | 2,660 | +14.1% | 0.00% | – |
| Q1 2019 | $261,000 | +13.0% | 2,332 | +1.8% | 0.00% | – |
| Q4 2018 | $231,000 | -21.2% | 2,290 | -1.3% | 0.00% | – |
| Q3 2018 | $293,000 | +33.2% | 2,320 | +154.9% | 0.00% | – |
| Q2 2015 | $220,000 | -12.4% | 910 | +2.2% | 0.00% | – |
| Q1 2015 | $251,000 | -2.7% | 890 | -18.3% | 0.00% | – |
| Q3 2014 | $258,000 | -43.5% | 1,090 | -43.5% | 0.00% | -100.0% |
| Q2 2014 | $457,000 | +5.8% | 1,930 | +47.3% | 0.00% | 0.0% |
| Q1 2014 | $432,000 | – | 1,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |